Our Team
Multi-disciplinary care for hematologic disorders
At CIBD, we believe that a family-centered, multidisciplinary team approach is essential to helping our patients live normal and productive lives. Care should begin at birth, and last a lifetime.
Diane Nugent, M.D.
Board President
President and Founder, CIBD
Board certified in pediatrics and pediatric hematology/oncology, Dr. Nugent specializes in all aspects of bleeding and clotting disorders, hematology, bone marrow failure, anemia, and immune disorders. Dr. Nugent founded CIBD with the goal of serving children and adults with genetic blood disorders, and their families, with comprehensive care tailored just for them. In 2005, she was named the National Hemophilia Foundation Physician of the Year, and later one of the Best Doctors in America in 2007-2008. She was also named Physician of the Year in Orange County. More recently in 2011, she received the Physician Circle of Care Award from Cal-Optima.
Dr. Nugent serves as a Clinical Professor at the University of California, Irvine (UCI). Among her peers, Dr. Nugent is the chair of review subcommittees for the National Heart, Lung, and Blood Institute/National Institutes of Health, and head of program projects for the hematology committees of the American Society of Hematology and International Society on Thrombosis and Hemostasis. Dr. Nugent received her fellowship training at Children’s Hospital Medical Center in Seattle and Fred Hutchinson Cancer Research Center. Upon graduating from the University of California, Los Angeles, School of Medicine, she completed her residency and internship at Denver Affiliated Hospitals in Colorado. Dr. Nugent speaks Spanish.
Amit Soni, M.D.
Board Vice President
Medical Director, CIBD
Board certified in pediatrics and pediatric hematology/oncology, Dr. Soni’s clinical and research focus is hemophilia and other bleeding disorders, especially as they relate to teens. In his pursuit to finding innovative ways to connect with teen patients with hemophilia, Dr. Soni worked on a grant for special strategic communications training from the Robert Wood Johnson Foundation to create interactive media aimed at connecting with teens with hemophilia. The goal is to provide teens with information about their disorder, so that they can take control of their health, and live productive lives as adults. More recently, he received the distinguished international Bayer Hemophilia Clinical Training Award. A member of the CIBD physician team, Dr. Soni has medical staff privileges at CHOC Children’s Hospital in Orange, CA. Dr. Soni completed medical school at Saint George’s University in Grenada, West Indies, completed his residency at the University of Medicine and Dentistry of New Jersey, and his fellowship at Children’s Hospital of Orange County where today he is a hemostasis/thrombosis clinical research fellow director. He earned certification in clinical trials and product development from UCI’s graduate program.
Mary E. Brown
Board Member
President & CEO, Sickle Cell Disease Foundation of California
In dedicating her career to education and research of sickle cell disease and related disorders, Ms. Brown has served a variety of healthcare-related non-profits. Currently, she is the Board Chair for the Community Health Charities of California, and also a board member of the Sickle Cell Disease Association of America, and Painted Turtle Camp, a summer camp for children with life-threatening illnesses. She also lends her leadership skills serving as the Director of Camp Crescent Moon. In 2012, Ms. Brown was recognized for her work by the American Camp Association when she received the Legacy Award for the ACA Southern California/Hawaii section. Ms. Brown is a graduate of California State University, Los Angeles where she earned her B.A. in education and psychology.
Randall Curtis, B.S.
MBA, Board Member
Chief Information Security Officer, State of California Department of Industrial Relations
Living with severe hemophilia, Randall Curtis has translated his condition into a benefit to others. His real-life experiences have led him to develop hemophilia database systems, collaborate with the Universal Data Collection Working Group at the CDC in Atlanta, and serve 25 years at the Genetic Disease Branch of the California Department of Health Services. Mr. Curtis holds a B.S. in Genetics, an M.B.A. in Computer Information Systems, and is also a certified Project Management Professional (PMP). He has presented data at national and international meetings, and is currently working on the Hemophilia Utilization Group Study (HUGS).
Michael Tarantino, MD
Board Member
Founder, Chief Medical Officer, and Chief Executive Officer of the Bleeding & Clotting Disorders Institute
With more than 30 years of experience in hematology, Dr. Michael Tarantino has devoted his career to the care and advancement of treatment for individuals with bleeding and blood clotting disorders. He is the Founder, Chief Medical Officer, and Chief Executive Officer of the Bleeding & Clotting Disorders Institute, and also serves as Medical Director of the Anticoagulation Consultation Service at St. Francis Medical Center. A tenured Professor of Pediatrics and Medicine at the University of Illinois College of Medicine, Dr. Tarantino is actively involved in teaching and research. He earned his medical degree from the University of Wisconsin School of Medicine and Public Health and is board certified in Pediatric Hematology and Oncology.
Michele Warner
Board Member
Director of Development Hemophilia Foundation of Southern CA
With more than 15 years of experience in fundraising and nonprofit development, Michele Warner serves as Director of Development at the Hemophilia Foundation of Southern California. She brings extensive expertise in revenue development, donor engagement, grant writing, and event support, having held leadership roles with organizations including March of Dimes, AltaMed Health Services, and The Archer School for Girls. As a parent of a child with severe hemophilia, Michele is deeply committed to advancing support, education, and resources for individuals and families affected by bleeding disorders in Southern California.
Derek Robertson, JD
Board Member
Managing Director Apogenics, Inc.
With more than 30 years of experience in healthcare policy and government pricing programs, Derek Robertson brings deep expertise in Medicare and Medicaid reimbursement, 340B Program compliance, and federal drug pricing regulations. He currently serves as Managing Director of Apogenics, Inc., providing 340B Program management services and mock HRSA audits for Hemophilia Treatment Centers. Mr. Robertson has held leadership roles across the hemophilia community, including with the National Hemophilia Foundation, academic medical centers, and the biopharmaceutical industry. He holds an MBA from Baruch College and a law degree from the University of Houston Law Center.
Troy Abercrombie
Board Member
Director of Accounting and Auditing Services and Chief Financial Officer at Talley, LLP
With more than three decades of experience in public accounting, Troy Abercrombie serves as Director of Accounting and Auditing Services and Chief Financial Officer at Talley, LLP. He provides financial leadership and advisory services to entrepreneurial businesses, with particular experience in manufacturing, distribution, healthcare, and transportation. His expertise includes financial reporting, internal controls, risk management, and strategic business planning. Mr. Abercrombie is a Certified Public Accountant and a graduate of California State University, Fullerton, where he earned his Bachelor of Science in Business.
Michael Warden
Chief Financial Officer
Vanessa Salinas, MD
Dr. Vanessa Salinas is board certified in pediatric hematology-oncology and in general pediatrics. She completed her pediatric hematology-oncology fellowship at CHLA and also completed a Coagulation and Bleeding Disorders fellowship at CHLA. She specializes in all areas of hematology with special focus in hemophilia and rare bleeding disorders, and red cell disorders, including sickle cell disease and thalassemia.
Dr. Salinas is interested in helping our hemophilia community and empowering our patients and families, through education and participation. She works closely with the Hemophilia Foundation of Southern California, and was awarded as the Medical Professional of the Year in 2019. Dr. Salinas participates in clinical research studies as principal investigator as well as co-investigator. Dr. Salinas advocates for recycling, and she enjoys nature and outdoor sports.